Credit Suisse Ag Bei Gene, Ltd. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Credit Suisse Ag holds 2,895 shares of BGNE stock, worth $656,325. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,895

Previous 1,668 73.56%

Holding current value

$656,325

Previous $300,000 50.67%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$141.8 - $181.47 $173,988 - $222,663	1,227 Added 73.56%	2,895 $452,000
Q4 2023 Feb 08, 2024	SELL	$158.67 - $201.58 $38,556 - $48,983	-243 Reduced 12.72%	1,668 $300,000
Q3 2023 Nov 13, 2023	BUY	$179.87 - $225.13 $22,124 - $27,690	123 Added 6.88%	1,911 $343,000
Q2 2023 Aug 11, 2023	SELL	$178.3 - $266.78 $24,605 - $36,815	-138 Reduced 7.17%	1,788 $318,000
Q1 2023 May 10, 2023	SELL	$215.53 - $274.5 $443,991 - $565,470	-2,060 Reduced 51.68%	1,926 $415,000

Q4 2022 Feb 13, 2023	SELL	$125.51 - $229.3 $9.47 Million - $17.3 Million	-75,481 Reduced 94.98%	3,986 $876,000
Q3 2022 Nov 10, 2022	BUY	$131.8 - $202.24 $122,046 - $187,274	926 Added 1.18%	79,467 $10.7 Million
Q2 2022 Aug 12, 2022	SELL	$121.11 - $216.05 $4.47 Million - $7.98 Million	-36,927 Reduced 31.98%	78,541 $12.7 Million
Q1 2022 May 16, 2022	BUY	$146.52 - $269.56 $853,772 - $1.57 Million	5,827 Added 5.31%	115,468 $21.8 Million
Q4 2021 Feb 14, 2022	BUY	$248.56 - $389.34 $4.16 Million - $6.51 Million	16,727 Added 18.0%	109,641 $29.7 Million
Q3 2021 Nov 12, 2021	BUY	$249.6 - $403.14 $2.25 Million - $3.64 Million	9,028 Added 10.76%	92,914 $33.7 Million
Q2 2021 Aug 16, 2021	BUY	$292.75 - $367.01 $996,521 - $1.25 Million	3,404 Added 4.23%	83,886 $28.8 Million
Q1 2021 May 14, 2021	SELL	$260.64 - $382.12 $9.2 Million - $13.5 Million	-35,296 Reduced 30.49%	80,482 $28 Million
Q4 2020 Feb 12, 2021	BUY	$221.31 - $316.61 $5.83 Million - $8.34 Million	26,352 Added 29.47%	115,778 $29.9 Million
Q3 2020 Nov 13, 2020	BUY	$189.18 - $286.44 $217,746 - $329,692	1,151 Added 1.3%	89,426 $25.6 Million
Q2 2020 Aug 12, 2020	SELL	$123.9 - $195.41 $1.56 Million - $2.46 Million	-12,586 Reduced 12.48%	88,275 $16.6 Million
Q1 2020 May 13, 2020	SELL	$121.84 - $173.19 $766,008 - $1.09 Million	-6,287 Reduced 5.87%	100,861 $12.4 Million
Q4 2019 Feb 12, 2020	BUY	$115.78 - $208.34 $2.49 Million - $4.48 Million	21,517 Added 25.13%	107,148 $17.8 Million
Q3 2019 Nov 12, 2019	SELL	$120.61 - $148.29 $646,107 - $794,389	-5,357 Reduced 5.89%	85,631 $10.5 Million
Q2 2019 Aug 14, 2019	BUY	$113.99 - $146.86 $814,002 - $1.05 Million	7,141 Added 8.52%	90,988 $11.3 Million
Q1 2019 May 14, 2019	SELL	$122.82 - $151.83 $4.04 Million - $4.99 Million	-32,895 Reduced 28.18%	83,847 $11.1 Million
Q4 2018 Feb 13, 2019	BUY	$107.01 - $175.15 $6.6 Million - $10.8 Million	61,721 Added 112.18%	116,742 $16.4 Million
Q3 2018 Nov 13, 2018	SELL	$152.62 - $189.66 $8.46 Million - $10.5 Million	-55,402 Reduced 50.17%	55,021 $9.48 Million
Q2 2018 Aug 14, 2018	SELL	$152.5 - $216.77 $21.7 Million - $30.8 Million	-142,201 Reduced 56.29%	110,423 $17 Million
Q1 2018 May 15, 2018	SELL	$97.41 - $177.22 $11.2 Million - $20.4 Million	-115,005 Reduced 31.28%	252,624 $42.4 Million
Q4 2017 Feb 14, 2018	BUY	$79.6 - $114.73 $9.22 Million - $13.3 Million	115,790 Added 45.98%	367,629 $35.9 Million
Q3 2017 Nov 14, 2017	BUY	$66.19 - $103.46 $16.7 Million - $26.1 Million	251,839	251,839 $26.1 Million

Others Institutions Holding BGNE

# of Institutions

300

Shares Held

30.4M

Call Options Held

147K

Put Options Held

195K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account